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Abstract 
Objective: The purpose of this study was to determine the influential factors of 
compliance and/or non-compliance with the gluten-free diet (GFD) for celiac disease 
(CD) individuals. 
Methods: The data collection instrument was a self-developed survey using 
kwiksurveys.com. The data were collected via online survey distribution to CD support 
group facilitators in nine Midwestern states. CD support group facilitators assisted 
snowball sampling by distributing the online survey to other members of the support 
groups. Qualitative data from survey question 12 was reviewed for themes and patterns 
and discussed in a narrative form. Statistical analysis of the data was done using SPSS 
software to determine the influential factors that predict compliance and/or non­
compliance with the GFD. 
Results: Of the 146 participants, 129 (88.4%) were female and 17 (11.6%) were male (5­
78 years old). Participants had a mean age at diagnosis of CD of 39 ± 17 years. The 
current study was unable to accept any of the research hypotheses; however, the data 
found that 24.0% of the variance in compliance with the GFD can be determined when 
knowing the subject's age at diagnosis, current knowledge of the GFD, influence of 
social pressures and situations, and availability of GF foods. The common challenges 
and strategies presented by the participants in question 12 support the findings of the 
study. 
Conclusions: Compliance rates with the GFD for CD individuals could be increased with 
knowledge of the individual's age at diagnosis, knowledge of the GFD, influence of 
social pressures and situations, and availability of GF foods 24.0% of the time. 
ii 
Understanding these and other factors that contribute to compliance rates is important for 
health care practitioners in order to improve educational strategies for effective treatment 
of CD using the GFD. 
iii 
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Chapter 1 
INTRODUCTION 
The prevalence of Celiac Disease (CD) has grown drastically in the past few 
decades. It has changed from a rare condition to a commonplace disease in a relatively 
short amount oftime. Today, "CD affects 1 in 133 Americans" (Fasano et aI., 2003), 
corresponding to about three million Americans that have the CD genotype. If left 
undiagnosed or untreated, CD can have multiple severe complications on the individual's 
health such as short stature, osteoporosis, infertility, neurological disorders, and many 
others. Currently, following a gluten-free diet (GFD) is the primary treatment for CD. 
Strict adherence to a GFD is challenging and is a life-long lifestyle change for individuals 
diagnosed with the disease. In an effort to improve education strategies for effective 
treatment of CD using the GFD, understanding compliance rates with the GFD for CD 
individuals is desired. 
Purpose ofStudy 
The purpose of this research project was to determine the influential factors of 
compliance andlor non-compliance with the GFD for CD individuals. 
Research Questions 
The research questions included: 
1. 	 Does age of diagnosis significantly predict compliance andlor non-compliance 
with the GFD? 
2. 	 Does knowledge of the GFD significantly predict compliance andlor non­

compliance with the GFD? 

2 
3. 	 Does the availability of gluten-free (GF) food significantly predict compliance 
and/or non-compliance with the GFD? 
4. 	 Do social pressures and situations significantly predict compliance and/or non­
compliance with the GFD? 
5. 	 Does the severity of physical symptoms of CD significantly predict compliance 
and/or non-compliance with the GFD? 
6. 	 Does the cost of GF foods significantly predict compliance and/or non­

compliance with the GFD? 

Research Hypotheses 
Hypotheses of this research project included: 
1. 	 Early diagnosis of CD will predict significantly (p~O.05) improved compliance 
with the GFD. 
2. 	 Increased knowledge of the GFD will predict significantly (p~O.05) improved 
compliance with the GFD. 
3. 	 Availability of GF foods will predict significantly (p~O.05) improved compliance 
with the GFD. 
4. 	 Social situations will increase pressure which will predict significantly (p:-=::O.05) 
decreased compliance with the GFD. 
5. 	 Severe physical symptoms of CD will predict significantly (p~O.05) increased 
compliance with the GFD. 
6. 	 The high cost of GF foods will predict significantly (p~O.05) decreased 

compliance with the GFD. 
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Significance of the Study 
This study is significant and will contribute to the current body of research by 
providing health care practitioners with a better understanding of compliance rates with 
the GFD for CD individuals. The information may be used to better understand 
education techniques for dietary instruction. Participants will contribute to the 
understanding of CD and the challenges individuals face with the GFD. 
Limitations of the Study 
This study was limited to individual's self-reported diagnosis of CD and did not 
attempt to clinically diagnosis CD among participants. This study was also limited by 
individual's self-rating of knowledge of the GFD and did not attempt to test the 
individual's knowledge of the GFD. Due to electronic distribution of the data collection 
instrument, the study was limited to those who have access to a computer with an internet 
connection. This study was limited to members of CD support groups, and may induce 
bias from participants already actively perusing techniques for overcoming challenges 
associated with the GFD. 
Definition of Terms 
Below are the terms that were defined for clarity of the research: 
1. 	 Compliance is the act of conforming to the guidelines; an act of following a 
prescribed treatment. 
2. 	 The Gluten-Free Diet (GFD) is the sum of foods consumed by an individual 
that are free from ingredients derived from gluten containing products such as 
wheat, barley, or rye. 
3. Non-compliance is the act of not following a prescribed treatment. 
4 
Chapter 2 
REVIEW OF LITERATURE 
According to Zwloinska-Wcislo and colleagues, CD is a "chronic inflammatory 
disease of the gastrointestinal (01) tract of autoimmune etiology in genetically 
predisposed individuals" (Zwloinska-Wcislo, Oalicka-Latala, Rudnicka-Sosin, & 
Rozpondek, 2009, p. 370). The Meir Medical Center in Israel defines CD as a prevalent, 
genetically determined, autoimmune, chronic inflammatory state caused by intolerance of 
gluten that results mainly in 01 manifestation (Nemet, Raz, Zifman, Morag, & Eliakim, 
2009). The American Dietetic Association (ADA) agrees that CD is an autoimmune 
reaction to the protein gluten causing damage to the small intestine in patients with the 
genetic condition (American Dietetic Association [ADA], 2009). The Mayo Clinic of 
Rochester, Minnesota, states the same conclusions that CD is a digestive disease 
triggered by the consumption of the protein gluten causing damage to the 01 tract (Mayo 
Foundation for Medical Education and Research [MFMER], 2008). Worldwide, CD is 
defined through research as a genetic autoimmune disorder with symptoms brought on by 
the consumption of the protein gluten. Multiple researchers agree and the definition of 
CD used in practice is unifoffil worldwide (Blaska, 2007; McGowan, Castiglione, & 
Butzner, 2009; & Darewicz, Dziuba, & Minkiewicz, 2008). 
Description of Celiac Disease (CD) 
The protein gluten is comprised of the storage proteins of wheat (Schuppan, 
Dennis, & Kelly, 2005). The components of the storage proteins are called ethanol­
insoluble glutenins and alcohol-soluble gliadins (Schuppan et aI., 2005 & Shan & Khosla, 
2007). The ethanol-insoluble gluten ins are the structures commonly thought of in baking 
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("Getting out the Gluten", 2009). Gluten, from the Latin word for glue, is responsible for 
making the dough resilient and stretchy allowing for baked goods to hold their desired 
structure ("Getting out the Gluten", 2009). Wheat variants like rye and barley produce 
similar gliadins and glutenins, contain a high percentage of the amino acids glutamine 
and proline, and form similar complex molecular structures (Schuppan et al., 2005 & 
"Celiac Disease: Gluten Sensitivity Enteropathy", 2007). Molecular components of oats 
and rice differ and are believed to not be associated with the inflammatory response. 
Research conducted by Dr. Schuppan focuses on a part of the gliadin peptide in wheat 
called the alpha-gliadin as the causative agent in the pro-inflammatory response in human 
studies (Schuppan et al., 2005). This alpha-gliadin component cannot be broken down by 
digestive enzymes. In rye, the structure that cannot be broken down is called secalin and 
in barley it is called horde in ("Getting out the Gluten", 2009). 
When these proteins are absorbed into the walls of the small intestine by celiac 
patients, the immune system misreads the signal and sees the proteins as invaders instead 
of nutrients ("Getting out the Gluten", 2009 & Kaukinen, Collin, Laurila, Kaartinen, 
Partanen, & Maki, 2007). The immune system releases an inflammatory response that 
causes damage to the tissues ("Getting out the Gluten", 2009). The damage can be 
extensive to the villi of the small intestine causing them to lose their shape and ability to 
produce digestive enzymes. The loss of the digestive enzymes makes it difficult for the 
surrounding villi to absorb other nutrients the body needs ("Getting out the Gluten", 
2009). 
Currently, the best and most common treatment for CD is strict adherence to a 
GFD (Neiwinski, 2008). It is important that dietitians, who playa critical role in the 
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management of CD, be up-to-date with the current teachings of a GFD (Shepherd & 
Gibson, 2006). Avoiding gluten containing products like wheat, barley, and rye is 
essential to the GFD (Amerine, 2006). Due to varying symptoms among CD patients, the 
amount of tolerable gluten is wide-ranging (Akobeng & Thomas, 2008). A study 
conducted by Akobeng and Thomas tried to find a tolerable threshold for gluten among 
CD patients. Some patients tolerated 34-36 mg of gluten per day while others developed 
intestinal damage form only 10 mg of gluten per day. There is not a common tolerable 
threshold for all CD patients, and as a result, dietary changes are strictly individualized 
(Akobeng & Thomas, 2008). 
Dr. Schuppan recognizes the difficulties this presents to CD patients and 
discusses a few of the alternative treatments currently being studied (Schuppan et aI., 
2005). Pharmaceutical companies are looking for drug treatments that would block the 
absorption of gluten ("Getting out the Gluten", 2009 & Baldassarre, Laneve, Grosso, & 
Laforgia, 2008). The treatment is progressive and if successful, may provide a guide for 
the research and treatment of other autoimmune diseases, but Food and Drug 
Administration (FDA) approval has not been received. The current standard for the 
management of CD is the elimination of gluten from the diet. 
The National Institute of Health (NIH) recommends that CD patients avoid foods 
containing wheat (wheat germ, flour/wheat starch, etc), barley, and rye (National Institute 
of Health [NIH], 2007). It is important to follow this diet in order to control symptoms, 
heal damage to the intestines, and prevent any further damage to the GI tract (McCreery, 
1976). The NIH says after beginning on a GFD, symptoms will start to decrease within 
days (NIH, 2007). After about two weeks of a truly GFD, patients report significantly 
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diminished symptoms and delayed gastric emptying returning to normal (Mason, 2009 & 
Perri, Pastore, Zicolella, Annese, Quitadamo, & Andriulli, 2000). The small intestine 
will heal in 3 to 6 months for children and potentially years for an adult (NIH, 2007). 
Once the intestine is healed, the villi will be able to properly absorb nutrients into the 
bloodstream (NIH, 2007). The ADA says that adherence to the GFD is a life-long 
lifestyle change necessary for management of CD in order to maintain nutrient absorption 
and avoid nutrient deficiencies (ADA, 2009). Following a GFD means removing any 
food product containing wheat, rye, or barley (NIH, 2007 & "Living Without Gluten", 
2009) such as grains, pastas, and cereals. CD patients can replace these foods in their 
diet with similar products that are gluten free; potato, rice, soy, amaranth, quinoa, 
buckwheat, or bean flour are gluten free (NIH, 2007). Vitamin and mineral supplements 
may need to be taken due to atrophy and malabsorption in the upper part of the small 
intestine ("Important Supplements for Gluten-Free Living", 2009). As the small intestine 
heals with compliance to the GFD, vitamin and mineral supplements can be adjusted to 
reflect individual needs ("Important Supplements for Gluten-Free Living", 2009). 
Adding oats to a GFD is controversial. In the past it was thought to be unsafe, but 
current findings say it may be acceptable to add oats to a GFD (Leeds, Hopper, & 
Sanders,2008). "Theoretically, oats should be tolerable; however, oats are traditionally 
contaminated with wheat flour during milling which brings up safety concerns for CD 
patients" (Leeds et al., 2008, p. 158). One study published by British Medical Bulletin 
tried the reintroduction of oats to CD patients only after their symptoms had resolved and 
antibodies became negative. If the CD patient experienced a return of symptoms after 
consuming a non-contaminated oat source, the patient was thought to be intolerant of oats 
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as well as having CD (Leeds et aI., 2008). Another study conducted over a 12-month 
period in Finland using 32 adult patients (19 female, 13 male) found that using oats as a 
part of a GFD in the treatment of CD is safe in both short and long term utilization 
(Kemppainen, Heikkinen, Ristikankare, Kosma, Sontag-Strohm, & Brinck, 2008). The 
study followed the subjects with a daily intake of 100 grams of oats for 12 months. The 
subjects were split into two groups at random with one group using regular oats and the 
other group using unkilned oats. After 6 months, the groups switched so the group using 
regular oats were now using unkilned oats and vice versa. After the 12 months, the study 
found no significant changes in the duodenal biopsies, in the levels of endomysial 
antibodies or in the well-being of the patients. Thus, large amounts of oats in either 
kilned or unkilned form pose no real threat to adult CD patients and can be viewed as 
safe to add to a GFD (Kemppainen et aI., 2008). 
A third study conducted in 2008 in Norway found that most adult CD patients 
can tolerate oats as a part of a GFD (Guttormsen, Lovik, Bye, Bratlie, Morkrid, & 
Lundin,2008). The study collected serum from 136 patients with controlled CD and 139 
controls to evaluate elevated IgA antibodies to oat prolamins. The study found that both 
oat-eating and non-oat-eating CD patients had elevated IgA levels to wheat, oats, and 
tissue trans glutaminase compared to healthy controls. The study concluded that oats do 
not contribute to increased levels of IgA in adult CD patients and can be tolerated on a 
GFD. These research results provide evidence that oats are a safe substitute for wheat 
and wheat products in a GFD. Like all things in nutrition, adding oat grain to the GFD 
should be evaluated on case by case bases, but it does not seem to be related to the 
intestinal inflammatory response of CD (Guttormsen et aI., 2008). 
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Consequences of Undiagnosed/Untreated CD 
There are multiple complications that could arise due to undiagnosed or untreated 
CD. Children with undiagnosed or untreated CD may not reach their full height potential 
resulting in short stature as an adult (Tau, Mautalen, De Rosa, Roca, & Valenzuela, 
2006). Adults with undiagnosed or untreated CD may experience bone loss and the 
development of osteoporosis (Sategna-Guidetti, Grosso, Grosso, Mengozzi, Aimo, & 
Zaccaria, 2000). Both women and men affected by CD may experience a degree of 
infertility if left undiagnosed or untreated (NIH, 2007), and neurological disorders may 
arise with the progression of CD (Martin, Romito, Pepe, De Vivo, Merola, & Limatola, 
2006). 
Short Stature and CD 
Undiagnosed or untreated CD has been linked to multiple nutrient deficiencies 
and autoimmune disorders resulting in complications such as short stature (Radlovic, 
Mladenovic, & Lekovic, 2009). Short stature may be a common presentation of CD for 
children as illustrated by a study conducted in India by Bhadada and colleagues 
(Bhadada, Bhansali, Kochhar, Menon, Sinha, & Dutta, 200S). The study involved 176 
children and followed their growth for a two year period. All the children were 
considered to have short stature at the beginning of the study. Screenings and tests were 
performed to diagnose the etiology of their short stature. The study found that 15.3% of 
the children with short stature also had CD making it the single most common cause. 
The measured growth rate of the 15.3% was 2.9 +/- 0.49 cm/year with untreated CD. 
Once a GFD was administered the growth rate of those with CD increased to S.9 +/- 2.2 
cm/year during the follow up period of six to nine months (Bhadada et aI., 200S). The 
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increase in growth rate after the initiation of the GFD, seen in this study in India and 
other studies, indicates that short stature may be due to malnutrition caused by CD 
(Radlovic et aI., 2009). 
The study in India proposes three mechanisms for the cause of short stature in 
CD patients; the first is malabsorption induced malnutrition (Bhadada et aI., 2008). CD 
can cause protein energy malnutrition as well as vitamin D and calcium malabsorption 
(Bhadada et aI., 2008). Calcium and vitamin D contribute to bone growth and health and 
without proper amounts of these nutrients bone may not reach maximum density and 
growth ("Osteoporosis and Digestive Disorders", 2008). The second cause may be 
attributed to a growth hormone resistance seen by the elevated growth hormone levels 
and the low circulating insulin levels in the children (Bhadada et aI., 2008). Growth 
hormone and circulating insulin are responsible for growth from early childhood to 
puberty (Bhadada et aI., 2008). Poor nutrition status due to malabsorption can influence 
the production of insulin and hinder growth rate in children (Ingegnosi, Caruso-Nicoletti, 
D'Amato, D' Annunzio, & Lorini, 2008). The third cause outlined by the study is 
hypogonadism, which attributes to low gonadotrophins and low testosterone also 
delaying peak bone mass and inhibiting pubertal growth spurts (Bhadada et aI., 2008). 
Giovenale and colleagues conducted a study in 2006 which tested 7066 children 
(2-14 yrs) for growth hormone deficiency (GHD) and CD (Giovenale, Meazza, 
Cardinale, Sposito, Mastrangelo, & Messini, 2006). Of those tested, 650 had GHD and 
44 had CD. The association between the two conditions was found in only 16 children 
making up 0.23%. Those 16 children did not grow for 1 year while on a GFD and thus 
GH treatment was started to initiate growth. The data were not overly significant and so 
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the conclusion was to have children with CD showing no catch-up growth after 
administration of a GFD to be screened for GH deficiency (Giovenale et ai., 2006). 
A study in Italy looked at 1066 children with short stature and found 210 (19.7%) 
had GHD and 12 had CD (Bozzola, Giovenale, Bozzola, Meazza, Martinetti, & Tinelli, 
2005). After the 12 CD children were put on a GFD for one year, nine showed a positive 
effect on growth rate. This study also indicates children with CD should be screened for 
GHD if growth rate does not improve with a GFD after an appropriate amount of time 
(Bozzola et ai., 2005). 
The studies mentioned show CDs relation to short stature may be primarily 
attributed to malabsorption and possibly linked to GHD (Bhadada et ai., 2008; Giovenale 
et ai., 2006; & Bozzola et ai., 2005). In most cases, the children in these studies 
improved their growth rate after a GFD was administered and intestinal damage was 
repaired enabling increased absorption of nutrients like calcium and vitamin D. With 
proper nutritional status, bone will have the nutrients it needs to reach full growth 
potential (Radlovic et ai., 2009). 
Osteoporosis and CD 
Around 30% of newly diagnosed CD patients have a degree of bone loss 
(Mangione, 2008). If that bone loss is left untreated, osteoporosis has an increased 
chance of development (Mangione, 2008). Research in past years indicates that CD 
patients have a lower bone mineral density, which is a risk factor for fractures 
(Ludvigsson, Michaelsson, Ekbom, & Montgomery, 2007). A study was conducted in 
Sweden to assess the association between CD and bone fractures (Ludvigsson et aI., 
2007). They followed 65,000 individuals from 1964 to 2003, and 13,000 with CD in the 
12 
same time period. At the end of the study, they calculated a hazard ratio for the groups 
and found that CD had significant influence on hip and other fractures after CD diagnosis 
(Ludvigsson et al., 2007). 
A study in 2001 followed 255 women (all showing signs of osteoporosis), to 
understand the prevalence of CD in osteoporotic women (Nuti, Martini, Valenti, Giovani, 
Salvadori & Avanzati, 2001). After the first CD screening, 53 women tested positive for 
CD. Bone metabolism was then evaluated with a series of tests and found that 24 women 
with CD antibodies had a significant reduction in serum calcium along with other blood 
chemistry signs of decreased bone metabolism. The study concluded that undiagnosed 
CD can increase calcium malabsorption, cause an unavailability of vitamin D, and result 
in marked bone loss (Nuti et al., 2001). 
Reduced bone mineral density is often seen in untreated CD patients as a result 
of malabsorption (Capriles, Martini, & Areas, 2009). It could also be associated with 
pro-inflammatory cytokines or a misbalanced bone remodeling. A study in 2009 in 
Brazil suggested chronic inflammation found in untreated CD may increase production of 
cytokines, increasing bone resorption and bone loss. The study concludes that a GFD 
can help increase bone mineral density in children and help reduce the risk for 
development of osteoporosis later. Capriles says this method works well for children but 
significant increases in bone mineral density were not seen for adult CD patients on a 
GFD (Capriles et al., 2009). 
Agardh conducted a study in Sweden in 2009 that looked at the association 
between the serum markers (CD antibodies) and decreased bone mass and the incidence 
of fractures in middle-aged women (Agardh, Bjrck, & Agardh, 2009). A total of 6480 
13 
women filled out surveys, had x-rays, and underwent blood tests to evaluate the 
correlation. The results showed a connection between those women who had high levels 
of the CD antibody and a decrease in bone mass. These 59 women (ages 50 to 64) had a 
higher prevalence of osteoporosis and an increased frequency of fracture (Agardh et aI., 
2009). 
These studies illustrate an association between osteoporosis and CD and bring up 
the questions of the mechanism behind the connection. The mechanism is explained by 
Zofkov in a study conducted in 2009. Zofkov (2009) explains that over production of 
certain cytokines can increase bone resorption, which is also increased by 
hyperparathyroidism connected with malabsorption of calcium and vitamin D (Zofkov, 
2009). The interaction of these mechanisms can cause a loss in bone mass. Zofkov and 
other researchers recommend calcium metabolism and bone mass screenings for CD 
patients (Zofkov, 2009 & Kavuncu, Dundar, Ciftci, Evcik, & Yigit, 2009). 
Infertility and CD 
CD may have a role in infertility for some patients, even if GI symptoms are not 
present (Seungdamrong & McGovern, 2007). An estimated one in 80 pregnancies may 
be affected by CD, and if untreated may result in miscarriage, intrauterine growth 
resistance (IUGR), or stillbirth (Anjum, Baker, Robinson, & Aplin, 2009). 
Malabsorption induced malnutrition may be one factor contributing to the negative 
pregnancy outcomes. The inappropriate production of cytokines in the GI tract causes 
atrophy of the villi that may inhibit vitamin and mineral absorption important for 
pregnancy (Seungdamrong & McGovern, 2007). Studies have shown that increased 
folic acid intake during pregnancy reduces the risk of neural tube defects in offspring 
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(Wolff, Witkop, Miller, & Syed, 2009). For CD patients, folic acid absorption can be 
affected by villeous atrophy and inadequate amounts of folic acid may contribute to low 
birth weight, preterm birth, and birth defects (Seungdamrong & McGovern, 2007). Low 
folic acid levels may also contribute to increased homocysteine levels, which is a risk 
factor for recurrent miscarriages (Haines, Anderson, & Gibson, 2008). Adequate iron 
status during pregnancy is shown to aid in early brain development, tissue oxygenation 
and energy metabolism, and neurodevelopment (Rioux, Lindmark, & Hernell, 2006). 
Malabsorption of iron during pregnancy due to CD may cause delayed brain 
development, neurological conditions, and impaired functional status of the infant 
(Seungdamrong & McGovern, 2007). Inadequate B complex vitamins during pregnancy 
may attribute to failure to thrive, developmental delays, and megaloblastic anemia in 
infants (Zengin, Sarper, & Caki Kil, 2009). Lack of absorption of B complex vitamins in 
CD patients during pregnancy may result with the same consequences (Seungdamrong & 
McGovern, 2007). 
Placenta function may be compromised during pregnancy for CD women causing 
IUGR. IUGR has a nine-fold increased incidence in CD women and may increase 
morbidity and mortality during pregnancy (Anjum et aI., 2009). A study looking at the 
function of autoimmune immunoglobulin A (IgA) found that IgA from the mother 
became associated with antigens at the syncytial surface of the placenta which inhibited 
tissue transglutaminase (TGases) function. Tgase plays a role in trophoblast apoptosis 
and if inhibited causes the placenta to carry a high volume of IgA which may lead to 
developmental or functional impairment for the embryo (Anjum et aI., 2009). 
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Both women and men have reported infertility in association with CD (NIH, 
2007). Women report increased infertility, recurrent spontaneous abortions, and preterm 
delivery and men report reduced fertility and sexual dysfunction related to CD. The 
mechanisms discusses above present some correlation between infertility and CD 
however no conclusive evidence has been reported. Further research is needed to 
determine the actual incidence of infertility among CD individuals (NIH, 2007). 
Neurological Disorders and CD 
In recent decades, neurological conditions have been reported in some CD 
patients (Freeman, 2008 & Grossman, 2008). For some, the discovery of these 
neurological conditions may be the initial presentation of CD and lead to its diagnosis 
(Freeman, 2008). While in others, the neurological conditions may have been brought 
on by malabsorption due to CD (Freeman, 2008; Niemer, 2007; & Hu, Murray, & 
Greenaway, 2006). Depending on the degree of atrophy in the small intestine, 
conditions like Wemicke-Korsakoff syndrome and Beri-beri may develop due to 
malabsorption of vitamins (Freeman, 2008). Some studies suggest a GFD may have a 
positive effect on neurological symptoms while others show a continual progression of 
the condition. Further research is needed to determine the effectiveness of adhering to a 
GFD on neurological conditions (Freeman, 2008). 
The autoimmune mechanism responsible for the development of neurological 
conditions in CD patients is unknown but one study hypothesized that a hormonal 
immune mechanism is involved (Briani, Zara, & Alaedini, 2008). In this study, 71 CD 
patients were assessed for neurological conditions by screening serum antibodies to 
neural antibodies. Neurological conditions like headache, depression, entrapment 
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syndromes, peripheral neuropathy, and epilepsy were found in 22.5% of CD patients 
tested. Follow up of the 22.5% did not show any changes in serum antibodies regardless 
of diet. This study suggests a GFD does not provide positive effects on neurological 
condition development (Briani et al., 2008). 
Another study at Cornell University suggests the hormonal immune mechanism of 
molecular mimicry between gliadin and nervous system proteins (Alaedini, Okamoto, & 
Briani,2007). They looked at cross-reactivity of animal and human anti-gliadins Abs 
and nervous system Ags. The cross-reactivity of rabbits to synapsin I, a group of 
neuronal phosphoporteins involved in regulation of neurotransmitter release, was strong. 
In humans with CD, the anti-synapsin Ab reactivity was also strong in contrast to the 
absence of anti-synapsin Ab reactivity in control subjects. This suggests CD may 
contribute to increased anti-synapsin Ab reactivity and the development of neurological 
conditions (Alaedini et al., 2007). 
Other studies discuss the mechanism of Tgases in CD individuals and the 
development of neurological disorders (Tau et al., 2006; De Vivo & Gentile, 2008; & 
Gentile & Cooper, 2004). Tgases are a family of enzymes that catalyze cross-linking 
reactions in the body for important functions like blood clothing, hair follicle 
differentiation, assembly and remodeling of the extracellular matrixes, cell signaling and 
apoptosis (Tau et al., 2006; Wodzinska, 2005; & Sblattero, Glorian, Azzoni, Zyla, Park, 
& Baldas, 2002). Tgases may contribute to atrophy in the small intestine by premature 
cell apoptosis and matrix degeneration of the villi. Truncated villi are responsible for 
malabsorption and may contribute to neurological conditions (De Vivo & Gentile, 2008). 
Further research is needed to determine if increased levels of Tgases are a causative 
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factor in neurological disorder development; however one study found Tgases may create 
antigenic determinants for the production of autoantibodies in CD (Wodzinska, 2005). 
Increased neurological autoantibodies in body tissues may increase nerve cell apoptosis 
and the development of Alzheimer's, Huntington's, Parkinson's, and other 
neurodegenerative diseases (Niemer, 2007; Wodzinska, 2005; & Zelnik, Pacht, Obeid, & 
Lerner, 2004). 
Progressive research in new therapeutic treatments for neurodegenerative diseases 
focuses on Tgase inhibition (Gentile & Cooper, 2004 & Wodzinska, 2005). One study 
using mice showed an increase in lifespan when Tgase 2 was knocked out (Gentile & 
Cooper,2004). Cystamine, an in vitro Tgase inhibitor, was able to be converted to the 
potent antioxidant cysteamine in vivo potentially alleviating oxidative stress on affected 
mice brains (Gentile & Cooper, 2004). This study is not conclusive; however it has made 
Tgase activity a target for therapeutic research to discover inhibitors of Tgase enzymes 
(Gentile & Cooper, 2004; Wodzinska, 2005; & Poloni, Vender, & Bolla, 2009). 
Treatment using GFDIPotential Factors Influencing Compliance 
Currently, the best and most common treatment of CD is strict adherence with the 
GFD. However, not all individuals diagnosed with CD are successful at following the 
GFD as closely as necessary for proper recovery from and prevention of symptoms. 
Research outlines potential factors that influence individuals diagnosed with CD to either 
comply with the GFD or to not comply with the GFD. 
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Financial Restraint 
The GFD can be considered an expensive diet as determined by Lee and 
colleagues in a study conducted in 2007. The study compared 11 products (regular 
wheat-based and their gluten free counterparts) to evaluate the economic burden of 
adhering to a GFD (Lee, Ng, Zivin, & Green, 2007). After assessing "specific brand, 
weight, package size, venue, and geographic location within the United States" (Lee et 
al., 2007, p. 424), the study concluded that GF foods are considerably more expensive 
than regular, gluten-containing foods and are not as readily available. This study 
suggests that the financial burden of GF foods may impact compliance with the GFD for 
CD individuals (Lee et al., 2007). More research and evidence is needed in this area to 
draw more concrete conclusions. 
Social Pressures 
Social situations present pressure for CD individuals to comply or not comply 
with the GFD. A study by Olsson and colleagues looked at adolescents with CD and 
sought to determine why adolescents comply, occasionally comply, or do not comply 
with the GFD (Olsson, Hornell, Ivarsson, & Sydner, 2008). The study assessed 47 CD 
adolescents (ages 15-17 years old), broken down into 10 focus groups, and their everyday 
social settings in relation to compliance or non-compliance with the GFD. After analysis 
of the focus group interviews, the majority of adolescents agreed that being at home was 
the easiest place to comply with the GFD and eating out with friends or at school was the 
most difficult place to comply with the GFD. "The attitudes and behaviors of significant 
others (teachers, friends, etc) affected the decision to comply or not in different social 
situations" (Olsson et al., 2008, p. 362). Feelings of embarrassment fueled non­
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compliance as well as not wanting to be a burden to anyone else. The study concluded 
that compliance with the GFD was complex and was influenced by "limited knowledge, 
poor availability, low sensory acceptance, inadequate social support, and social 
inconvenience" (Olsson et aI., 2008, p. 365). A limitation of this study may be that 
adolescents already feel low self-esteem and an increased desire to be accepted by peers 
during this stage of development. More research is needed in a wider age group to 
determine the influence social pressures have over individuals with CD and compliance 
or non-compliance with the GFD (Olsson et aI., 2008). 
Gluten-Free Food Availability 
Availability of GF foods seems to be a factor for compliance and was mentioned 
in both studies lead by Lee and Olsson. Another study conducted by Zarkadas and 
colleagues in 2006 also mentions the influence availability of GF foods has on the rate of 
compliance with the GFD (Zarkadas, Cranney, Case, Molloy, Switzer, Graham et aI., 
2006). The study assessed 2,681 CD individuals who were members of the Canadian 
Celiac Association (CCA) to evaluate the impact the GFD has on CD individuals. 
Zarkadas found that 15-20% of participants reported having difficulty with availability of 
GF foods most of the time (Zarkadas et aI., 2006). No studies were found that directly 
focused on availability of GF foods and the connection to GFD compliance. Further 
research is needed to determine if availability of GF foods has a significant impact on 
compliance or non-compliance with the GFD. 
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Physiological Influences 
The presence or absence of physiological symptoms may be a factor for 
determining compliance or non-compliance with the GFD for CD individuals. A study 
published in 2004 by Murray and colleagues aimed to examine the effect of the GFD on 
gastrointestinal symptoms of CD (Murray, Watson, Clearman, & Mitros, 2004). "A 
cohort of US patients evaluated at the University of Iowa from 1990 to 1997 was 
systemically surveyed about gastrointestinal symptoms before and after adhering to the 
GFD" (Murray et aI., 2004, p. 669). Prior to starting a GFD, 75% of participants said 
they experienced diarrhea and more than half of those with diarrhea reported stools 
suggestive of steatorrhea. "Sixty-one percent complained of frequent flatulence, and 
64% had urgency. Thirty-one percent complained of significant tenesmus, and 38% had 
experienced fecal incontinence" (Murray et aI., 2004, p. 669). The study found that the 
GFD was beneficial for both men and women at improving the presence of diarrhea, 
constipation, abdominal pain, bloating, and nausea or vomiting. Sixty-one percent of 
participants who had diarrhea originally reported resolution by six months after 
compliance with the GFD. The study concluded that the GFD will significantly reduce 
gastrointestinal symptoms of CD (p<0.001) (Murray et aI., 2004). Although not 
explicated stated by the study, it may be hypothesized that compliance may increase with 
the decrease of gastrointestinal symptoms. Further research is needed to determine the 
accuracy of the hypothesis. 
21 
Summary 
CD has become more prevalent in the past decades affecting nearly three million 
Americans (Fasano et al., 2003). It is important for practitioners to have a working 
understand of the condition in order to recognize symptoms, improve diagnostic time, 
and reduce the risk of developing additional complications (Martin, 2008). Strict 
compliance with the GFD is reported to provide protective benefits for CD patients from 
GI malignancies (Seraphin & Mobarhan, 2002». Research conducted by Corrao et al. in 
2002 reported by Seraphin showed this association and reported a relation between GFD 
compliance and decreased mortality rates in both symptomatic and asymptomatic CD 
patients. A standardized mortality ratio (SMR) was calculated over a 6-year study that 
showed an increase in deaths from small bowel lymphoma and other malignant diseases 
in patients not following the GFD (Seraphin & Mobarhan, 2002). Additional research is 
needed to determine the effects of malignant diseases associated with CD to better 
understand the relation with the GFD. Further research is needed to determine influential 
factors for compliance and/or non-compliance to the GFD in order to improve education 
strategies for effective treatment of CD using the GFD. 
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Chapter 3 
METHODOLOGY 
The purpose of this study is to determine the influential factors of compliance 
and/or non-compliance with the GFD for CD individuals. Research found that strict 
adherence with the GFD provides protective effects for the CD individual. This section 
discusses the design of the study, the sample, instrumentation, procedure for data 
collection and data analysis. 
Design of the Study 
The design of this study is a mixed-method survey analysis. There was one 
group of participants consisting of CD support group members from nine Midwestern 
states. Each participant followed the same research procedures. 
Sample 
Members of CD support groups based in Midwestern states (Illinois, Indiana, 
Iowa, Kansas, Michigan, Minnesota, Missouri, Ohio, and Wisconsin) were recruited for 
participation (See appendix A). A minimum of 50 members were required to provide a 
basis for estimating sampling error. To achieve the minimum sample, participation from 
multiple CD support groups within each state was necessary. 
Selection of sample 
The sample was selected based on convenience. All members agreeing to 
participate were included in the study. Electronic correspondence was initiated with the 
head of each CD support group, requesting participation from other members of the 
group. Participation was completely voluntary. No age or gender quota was established. 
Parents or legal guardians of minors (17 years of age or younger) with CD helped fill out 
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electronic surveys if they desired and by doing so gave consent for the minor. 
Participants were informed the study was voluntary and that they could withdraw at any 
point during the research project. 
Instrumentation 
The instrument used to conduct research in this study was a researcher-developed 
survey on CD and the GFD (see appendix B) using kwiksurveys.com. The survey was 
designed to collect data on influential factors for CD individuals in determining GFD 
compliance and/or non-compliance. Reliability of the instrument has not been 
established because this was the initial distribution of the survey. Face validity was 
established via peer review. Content validity was established via review by two experts 
in the field of nutrition and dietetics. Due to the Midwestern focus of the data, ecological 
validity for other regions of the United States like the east or west coast cannot be 
established. 
Procedure for Data Collection 
Participants were contacted via email and told that the focus of the research was 
to collect data on CD and the GFD. To avoid influencing the responses, the participants 
were not informed of the specific focus of the research (developing educational strategies 
for effective treatment of CD using the GFD by better understanding influences on 
compliance). Participant names and contact information were available to the researcher 
but excluded from the results. Participants were informed in the recruitment email about 
the purpose of the study, procedures, potential risks and discomforts, benefit of 
participation, confidentially, right to withdraw, and contact information for additional 
questions or concerns. By responding to the invitation to participate email, participates 
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gave informed consent. The link to the online survey was administered through email. 
Participants completed the survey online via the kwiksurverys.com website. Individual 
surveys were not seen by anyone other than the researcher and names of participants were 
kept confidential. After initial distribution of the link to the survey on June 1,2010, 
participants had 2 weeks to complete the survey online. After 2 weeks, the number of 
completed surveys were counted and the need for reminder emails and further participant 
recruitment was assessed. Reminder emails were sent to additional potential participants 
and the link was closed on June 30, 2010. 
Data Analysis 
Surveys were analyzed by kwiksurvey.com and a report was generated to present 
descriptive statistics using tables, frequencies, means, and ranges for questions one 
through eleven. Emerging themes and patterns of qualitative data in question 12 were 
tallied and reported using frequencies generated by kwiksurvey.com and discussed in a 
narrative form. Regression analysis using SPSS was used to determine the influential 
factors that predict compliance and/or non-compliance with the GFD and established 
statistical significance at p:S0.05. 
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Chapter 4 
RESULTS AND DISCUSSION 
The purpose of this study was to determine the influential factors of compliance 
and/or non-compliance with the GFD for CD individuals. Currently, there is no known 
cure for CD and the most common treatment is strict adherence with the GFD. However, 
not all individuals diagnosed with CD are successful at following the GFD as closely as 
necessary for proper recovery from and prevention of symptoms. Research question 
number one asked if age of diagnosis would predict compliance and/or non-compliance 
with the GFD. Research question number two asked if knowledge of the GFD would 
predict compliance and/or non-compliance with the GFD. Research question number 
three asked if availability of GF foods would predict compliance and/or non-compliance 
with the GFD. Research question number four asked if social pressures and situations 
would predict compliance and/or non-compliance with the GFD. Question number five 
asked if the severity of physical symptoms of CD would predict compliance and/or non­
compliance with the GFD. Question number six asked if the cost of GF foods would 
predict compliance and/or non-compliance with the GFD. 
Results 
The snowball effect enhanced distribution of the online survey and increased the 
response rate. Ninety initial invitation emails were sent to CD support group facilitators. 
Of the original 90, 30 (33%) completed surveys were received. An additional 60 
reminder emails were sent after the first 2 weeks and generated a response from 123 CD 
support group members. Of the total 153 surveys received, four were excluded from the 
analysis due to unanswered questions. Another three were excluded for being out of the 
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predetermined nine states. Data from a total of 146 completed surveys were analyzed. 
Demographic data, descriptive statistics and multiple regression analysis using 
kwiksurveys.com and SPSS software were used to analyze the responses from questions 
one through 11. Responses to the qualitative question number 12 were examined by the 
researcher and reported in narrative from. 
Demographic Data 
Of the 146 participants, 129 (88.4%) were female and 17 (11.6%) were male 
(ratio 7.5/1). Participants ranged in age from 5-78 years old (mean= 45 ± 17 years) and 
the majority of participants were between the ages of 41-60 years old. The majority of 
participants were from Wisconsin at 27.4% (40), 15.1 % (22) were from Illinois, 14.4% 
(21) were from Michigan, 10.3% (15) were from Missouri, 8.9% (13) were from Kansas, 
8.9% (13) were from Minnesota, 7.5% (11) were from Ohio, 4.1 % (6) were from Iowa, 
and 3.4% (5) were from Indiana. The demographic data are shown in Table 1 and the 
state distribution is illustrated in Figure 1. 
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Table 1 
Characteristics of CD Support Group Facilitators and Members 
Characteristics (N=146) 
Current Age (years) 
1-20 13 
21-40 39 
41-60 63 
61-80 31 
Gender 
Male 17 
Female 129 
% 
8.9 
26.7 
43.2 
21.2 
11.6 
88.4 
Figure 1 
State Distribution of Participants 
- Illinois 
- Indiana 
- Iowa 
- Kansas 
- Michigan 
- Minnesota 
- Missouri 
- Ohio 
- Wisconsin 
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Figure 1. Note. Each participant indicated their current state of residence. The percentage 

of participants from each state is illustrated by the graph. 

Research Question 1: Does age ofdiagnosis of CD predict compliance and/or non­

compliance with the GFD? 

Participants indicated their age at diagnosis in question number four on the 
survey. Participants ranged in age at diagnosis from 1-74 years old with the mean being 
39 ± 17 years (female=38.8 ± 16.4 years, male=40.7 ± 21.7 years). The majority of 
participants were diagnosed between the ages of 21-60. Table 2 shows the distribution of 
age at diagnosis among participants. Age of diagnosis was negatively correlated with 
current rate of compliance (beta= -0.109). The negative correlation suggests that a 
change in rate of compliance reflects an inverse change in age. This change signifies a 
trend in the data that the younger the age of diagnosis, the higher the rate of compliance. 
Linear regression analysis using SPSS indicates that age at diagnosis can independently 
account for 1.2% of the variance in current rate of compliance (p>0.05). Although not 
statistically significant alone, when combined with current knowledge of the GFD, 
availability of GF foods, and influence of social pressures and situations in stepwise 
multiple regression analysis, 24.0% of the variance in current rate of compliance can be 
explained. This indicates that these four factors playa key role in determining current 
rate of compliance. 
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Table 2 
Distribution of Age at Diagnosis for Participants 
Age at Diagnosis (N=146) % 
1-20 19 13.0 
21-40 55 37.7 
41-60 59 40.4 
61-80 13 8.9 
Research Question 2: Does knowledge of the GFD predict compliance and/or non­
compliance with the GFD? 
Participants rated their current knowledge of the GFD in questions number five on 
the survey. Participants had a mean response of 9.3 ± 1.4 (10 being 100% knowledgeable 
and 1 being 100% not knowledgeable) indicating the majority of participants believed 
themselves to be 90% knowledgeable of the GFD. There was no significant difference 
between male and female (male= 9.1 ± 1.7, female= 9.3 ± 1.4) responses. Figure 2 
illustrates frequency of responses. Current knowledge was positively correlated with 
current rate of compliance (beta =0.365). Linear regression analysis using SPSS 
indicates that current knowledge of the GFD can independently account for 13.3% of the 
variance in current rate of compliance (p>0.05). Although not statistically significant 
alone, when combine with availability of GF foods, age at diagnosis, and influence of 
social pressures and situations in stepwise multiple regression analysis, 24.0% of the 
variance in current rate of compliance can be explained. Again, indicating that these four 
factors playa key role in determining current rate of compliance for CD individuals. 
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Figure 2 

Frequency of Responses of Self-Rated Knowledge of the GFD. 
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Figure 2. Note. The y-axis is the number of participants. The x-axis is the response 
indicated by each participant on the survey (1 to 10) of self-rated knowledge of the GFD. 
Research Question 3: Does the availability ofGFfoods predict compliance and/or non­
compliance with the GFD? 
Participants rated the availability of GF foods where they lived in question 
number seven on the survey. The mean response was 7.7 ± 2.0 (10 being 100% always 
available and 1 being 100% never available) indicating the majority of participants 
believed GF foods to be 77% available where they lived. Eleven percent of participants 
(17) reported GF foods to be available <50% of the time. There was no significant 
difference between male and female (male= 7.2 ± 2.5, female= 7.8 ± 2.0) responses. 
Figure 3 illustrates frequency of responses. Availability was positively correlated with 
current rate of compliance (beta = 0.303). Linear regression using SPSS indicates that 
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availability can independently account for 9.2% of the variance in current rate of 
compliance. Although not statistically significant alone, when combined with current 
knowledge, age at diagnosis, and influence of social pressures and situations in stepwise 
multiple regression analysis. 24.0% of the variance in current rate of compliance can be 
explained. Availability of GF foods is one of the four key components in determining 
current rate of compliance for CD individuals. 
Figure 3 
Frequency of Responses to Availability of GF Foods 
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Figure 3. Note. The y-axis is the number of participants. The x-axis is the response 
indicated by each participant on the survey (1 to 10) of availability of GF foods. 
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Research Question 4: Do social pressures and situations predict compliance and/or non­
compliance with the GFD? 
Participants rated how influential social pressures and situations were to their 
decision to comply with the GFD in question number eight on the survey. The mean 
response was 2.8 ± 2.7 (10 being 100% always influential and 1 being 100% never 
influential) indicating the majority of participants believe social pressures and situations 
to be minimally influential on compliance. Male participants tend to be more influenced 
by social pressures and situations (male= 4.2 ± 3.4) than female participants (female= 2.6 
± 2.6). Figure 4 illustrates frequency of responses. Influence of social pressures and 
situations were negatively correlated with current rate of compliance (beta = -0.210). 
Linear regression using SPSS indicates that influence of social pressures and situations 
can independently account for 4.4% of the variance in current rate of compliance. 
Although not statistically significant alone, when combined with current knowledge of 
the GFD, age at diagnosis, and availability of GF foods in stepwise multiple regression 
analysis, 24.0% of the variance in current rate of compliance and be explained. This 
result indicates that these four components are important in determining current rate of 
compliance for CD individuals. 
---------------------------------
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Figure 4 

Frequency of Responses to Influence of Social Pressures and Situations. 
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Figure 4. Note. The y-axis is the number of participants. The x-axis is the response 
indicated by each participant on the survey (l to 10) of influence of social pressures and 
situations on compliance with the GFD. 
Research Question 5: Does the severity ofphysical symptoms of CD predict compliance 
and/or non-compliance with the GFD? 
Participants rated the severity of their physical symptoms of CD in questions 
number nine on the survey. The mean response was 6.7 ± 2.9 (10 being 100% always 
severe and 1 being 100% never severe) indicating that the majority of participants found 
their physical symptoms to be 67% severe. There was no significant difference between 
male and female (male=6.6 ± 3.1, female=6.7 ± 3.0) responses. Figure 5 illustrates 
frequency of responses. Physical symptom severity was positively correlated with 
current rate of compliance (beta = 0.018). Although an important factor, severity of 
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physical symptoms was not statistically significant when detennining current rate of 
compliance. 
Figure 5 
Frequency of Responses to Severity of Physical Symptoms 
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Figure 5. Note. The y-axis is the number of participants. The x-axis is the response 
indicated by each participant on the survey (1 to 10) of severity of physical symptoms. 
Research Question 6: Does the cost ofGFfoods predict compliance and/or non­
compliance with the GFD? 
Participants rated how expensive they found GF foods to be in question number 
ten on the survey. The mean response was 8.7 ± 1.3 (10 being 100% always expensive 
and 1 being 100% never expensive) indicating participants find GF foods to be more 
expensive than their gluten-containing counterpart 87% of the time. There was no 
significant difference between male and female (male= 8.8 ± 1.3, female= 8.7 ± 1.3) 
responses. Participants were then asked in question number 11 on the survey to rate how 
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influential the cost of GF foods are on their decision to comply with the GFD. The mean 
response was 2.6 ± 2.7 (10 being 100% always influential and 1 being 100% never 
influential) indicating participants are influenced by the cost of GF foods 26% of the 
time. Male participants seemed to be more influenced by cost (male= 4.0 ± 3.8) than 
female participants (2.4 ± 2.5). Figure 6 illustrates frequency of responses. Cost of GF 
foods was negatively correlated to current rate of compliance (beta = -0.221). Although 
participants found GF foods to be expensive, they were not significantly influenced by 
the cost. 
Figure 6 
Frequency of Responses to Perceived Cost vs. Influence of Cost 
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Figure 6. Note. The y-axis is the number of participants. The x-axis is the response 
indicated by each participant on the survey (1 to 10) of perception of cost of GF foods as 
well as influence of cost of GF foods on compliance with the GFD. 
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Qualitative data: Survey questions 12 
Question 12 on the survey asked participants to share any experiences they have 
had while eating a GFD. One hundred participants responded to question 12 which were 
analyzed for common themes. Participants reported challenging situations related to 
eating a GFD as well as strategies they developed to overcome those challenges. 
Common challenges were eating out (30%), fears of cross-contamination while eating out 
(17%), severity of physical symptoms (16%), high cost of GF foods (14%), lack of or 
miss informationlknowledge of others (8%), traveling (5%), social pressures (4%), school 
lunches (4%), availability of GF foods (3%), and cross-cultural challenges (1 %). 
Eating out and cross-contamination presented the most difficult challenge for the 
majority of participants. Many indicated it was because of lack of options of GF foods 
on the menu, cross-contamination with gluten-containing foods in the kitchens, lack of 
education among kitchen staff and wait staff, and restaurants giving out miss or false 
information. Some participants reported it was easier to eat at home than try to find 
something that was safe on a menu at a restaurant. For example, one participant shared 
about the difficultly of going out to eat 
'Very difficult to go out to eat so we rarely do because of the high risk involved.' 
(Male, 35 years) 
Other participants described strategies for going out to eat that allow them to still 
enjoy dining out like anyone else. For example, one participant shared a strategy for 
finding GF foods. 
'There are now a number of restaurants in my area that have fresh gluten-free 
meals available and I always call the restaurants ahead of time'. (Female, 28 years) 
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Participants reported physical symptoms to be a challenge associated with CD and 
the GFD. Many reported that pain and discomfort was a reminder to stick to the diet and 
that any exposure to gluten would cause almost immediate bloating, cramps, and 
abdominal discomfort. This physical distress was enough to help the majority of 
participants maintain compliance with the GFD. For example, one participant shared her 
experience with the GFD. 
'I just remember that nothing tastes as good as being healthy feels'. (Female, 24 
years) 
The high cost of GF foods was also mentioned by participants as a challenge 
when trying to comply with the GFD. Many reported needing to find specialty food 
stores to locate GF products which would always be more expensive than normal grocery 
stores. Prepackaged GF products like baking mixes, snack foods, and breads were 
considered the most expensive GF foods by participants. For example, one participant 
shared her experience buying GF bread. 
'I now drive 45 minutes for bread that costs $5 and it only has 12 slices'. (Female, 
30 years) 
One participant reported a strategy for avoiding high costs of GF foods by 
shopping online. Online grocery stores offer foods at a less expensive price than in­
person grocery stores as well as allowing access to a wider variety of GF products 
nationwide which may not be available in the local area. 
Participants indicate that the lack of knowledge or miss information of others 
creates a challenge when trying to comply with the GFD. Miss or lack of information 
from friends, family, restaurant staff, health care professionals, teachers, co-workers, the 
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media, and food labels present a challenge to the CD individual. Participants suggested 
increasing education on CD in all areas to increase awareness of the condition and 
improve CD related information they receive. 
Traveling presents another challenge for CD individuals. Airports, different 
cities, and different countries were mentioned as the most challenging places to eat while 
traveling. Participants suggested bringing snacks and planning ahead when taking trips 
to avoid moments of non-compliance. 
Social pressures were mentioned by 4% of participants as a challenge for 
compliance with the GFD. Feelings of embarrassment, being a burden, causing a scene, 
not wanting to look different and not wanting to hurt someone's feelings were mentioned 
when discussing challenges with compliance. Of the 4% indicating social pressures as a 
challenge, most reported lack of knowledge of peers in social situations to create the 
issue surrounding compliance. For example, one participant shared his feelings about 
eating with others. 
'People give you a hard time about not eating certain foods and don't understand 
why you can't eat them'. (Male, 30 years) 
Educating others within social circles was a strategy one participant mentioned 
for decreasing the influence of social pressures on compliance with the GFD. 
Incorporating family and friends into the dietary counseling treatment of CD may help to 
address this issue. 
School lunches provided by the school lunch program presented a challenge for 
school age participants. Children feeling left out because of food and the risk of cross­
contamination due to uneducated kitchen staff create a challenge with compliance. 
39 
Parents of CD children suggested acting as an advocate and requesting school cooks to 
become educated about the condition as a strategy for helping their CD children increase 
compliance. 
Availability of GF foods as a challenge of compliance was only mentioned by 3% 
of participants in questions number 12 which is consistent with the response to question 
number seven. Availability of GF products is increasing and participants are finding it 
easier to purchase foods that are safe. Participants rated GF foods to be 77% available 
indicating the majority of participants do not find availability of GF foods to be a 
challenge associated with complying with the GFD. Of the 3% indicating availability as 
a challenge, the majority lived in rural areas and also mentioned an increase in the 
availability of GF products over time. For example, one participant shared her 
experience with the GF diet over 20 years with CD. 
'Very different at the beginning, 20 years ago-little to nothing available 
commercially. Now, things are popping up all over-that has been a nice change'. 
(Female, 68 years) 
Cross-cultural challenges were mentioned by one participant. Different cultural 
foods that CD patients are unfamiliar with, different preparation methods and the 
language barrier all present a challenge for compliance with the GFD. For example, the 
participant shared her experience with the language barrier in another country. 
'Trying to explain that you are gluten-free to a waiter here in the states is difficult, 
then try to do it with someone who does not speak English. Makes it much harder' 
(Female, 21 years) 
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The responses to survey question 12 consistently agreed with the quantitative 
responses to questions 1-11. The common challenges and strategies presented by 
participants support the findings of this study. 
Discussion 
CD is a much more common place disease today than it was only a few decades 
ago affecting 1 in 133 people in the United States (Fasano et aI., 2003). Currently, there 
is no known cure for CD and, if left untreated or undiagnosed, CD can have multiple 
severe complications on the individual's health. Strict adherence with the GFD is life­
long and presents a challenge for many individuals that are influenced by various factors. 
The purpose of this study was to determine the influential factors of compliance and/or 
non-compliance with the GFD for CD individuals. Understanding compliance rates will 
help to improve education strategies for effective treatment of CD using the GFD. A 
survey was developed and distributed to CD support group facilitators from nine 
Midwestern states online using kwiksurveys.com to determine influential factors 
contributing to compliance and/or non-compliance. 
Hypothesis 1,' Early Diagnosis of CD will predict significantly improved compliance with 
the GFD. 
The results from question four indicate that the majority of participants were 
diagnosed with CD between the ages of 21 and 60. Hypothesis 1 predicts that the earlier 
a patient is diagnosed with CD, the higher their rate of compliance with the GFD will be. 
Although the results point toward a negative trend, the relationship is not statistically 
significant (p2:0.05) and hypothesis 1 cannot be accepted alone. This finding contradicts 
with the findings of Hauser, Stallmach, Caspary, and Stein (2007) that reported the 
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younger the individual is at diagnosis corresponds with a decrease in their sense of well­
being (beta= -0.04, p=0.69). Hauser predicts that early age of diagnosis will decrease 
compliance due to a decrease in coping skills at an early age. As the CD individual 
grows, lack of coping skills may result in continued issues with compliance throughout 
life (Hauser et aI., 2007). 
In the current study, when age at diagnosis was considered with participants' 
responses to availability of GF foods, current knowledge of the GFD, and the influence of 
social pressures and situations, it played a role in determining rate of compliance; 
knowing the above four factors accounts for 24.0% of the variance in current rate of 
compliance. This finding is unique to the current study. No other studies have been 
published that address the specific four factors listed above. 
Hypothesis 2: Increased knowledge of the GFD will predict significantly improved 
compliance with the GFD. 
The results from question five indicate the majority of participants believe 
themselves to be 90% knowledgeable of the GFD. Hypothesis 2 predicts the more 
knowledge a CD individual has, the higher their rate of compliance will be. The results 
point toward a positive trend showing an increase in knowledge of the GFD predicts an 
increase in current rate of compliance 13.3% of the time. Current knowledge of the GFD 
alone is not statistically significant (p2:0.05) in predicting current rate of compliance and 
hypothesis 2 is rejected. In a study conducted by Anson (1990) aimed at assessing 
parental knowledge of the GFD and compliance rates for their CD children, they found 
that parents of compliance CD children could name all the GF foods from a menu (94%), 
understood the diet was for life (52%), and that CD affects the absorption of foods (70%). 
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They concluded that an increase in parental knowledge of CD and the GFD increased 
compliance for their CD children (Anson, Weizman, & Zeevi, 1990). These results agree 
with the current study that shows a positive correlation between increased knowledge of 
the GFD and increased compliance with the GFD. 
In the current study, when knowledge of the GFD is considered with participants' 
responses to availability of GF foods, age at diagnosis and influence of social pressures 
and situations, 24.0% of the variance in current rate of compliance is explained. There is 
a lack of research focused on these four factors and their contribution to current rate of 
compliance with the GFD. Further research is needed to determine the reliability of the 
current study's results. 
Hypothesis 3: Availability ofGFfoods will predict significantly improved compliance 
with the GFD. 
The results from question seven show the majority of participants believe GF 
foods to be 77% available where they live. Hypothesis 3 predicts the more availability of 
GF foods, the higher the rate of compliance with the GFD will be. Availability of GF 
foods is positively correlated with current rate of compliance suggesting an increase in 
availability of GF foods will predict an increase in current rate of compliance 9.2% of the 
time. Alone, availability of GF foods is not statistically significant (p~0.05) at predicting 
current rate of compliance and hypothesis 3 is rejected. However, when considered as a 
component with current knowledge of the GFD, age at diagnosis, and the influence of 
social pressures and situations, 24.0% of the variance in current rate of compliance is 
explained. This finding concerning availability alone is consistent with the research done 
by Zarkadas assessing the impact of the GFD for CD individuals. Zarkadas and 
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collegues found that 15-20% of participants are influenced by availability of GFD 
(Zarkadas et aI., 2006). There is a lack of research surrounding availability of GF foods 
and its impact on compliance with the GFD. Further research is needed on this issue 
alone and as a part of a multi-factorial influence on compliance. 
Hypothesis 4: Social situations will increase pressure which will predict significantly 
decreased compliance with the GFD. 
The results from question number eight on the survey show the majority of 
participants (n=81) are not significantly influenced by social pressures and situations. 
Hypothesis 4 predicts that social situations will increase pressure to decrease compliance 
with the GFD. Although the influence of social pressures and situations were negatively 
correlated with current rate of compliance, the relationship is not statistically significant 
(p~0.05) and hypothesis 4 is rejected. These results correspond with the majority of 
participants (85%) saying social pressures and situations do not influence their decisions 
to comply with the GFD >50% of the time. Research findings from Olsson et ai. (2008) 
focused on adolescents disagrees with these findings, saying feelings of embarrassment 
and not wanting to be a burden to others fuel non-compliance. The differences in results 
may be explained by the differences in mean ages of study samples. Adolescents may be 
more influenced by social pressures and situations than adults and older adults. 
In the current study, when influence of social pressures and situations is 
considered as a component with availability of GF foods, current knowledge of the GFD, 
and age at diagnosis, it predicts 24.0% of the variance in current rate of compliance. 
There is a lack of research focused on these four factors and their contribution to current 
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rate of compliance with the GFD. Further research is needed to determine the reliability 
of the current study's results. 
Hypothesis 5: Severe physical symptoms of CD will predict significantly increased 
compliance with the GFD. 
The results from question number nine on the survey indicate that participants 
found their physical symptoms to have a wide range in severity. Hypothesis 5 predicts 
that the more severe the physical symptoms from CD, the higher the rate of compliance 
with the GFD. Although there is a positive correlation, severity of physical symptoms 
only predicts an increase in current rate of compliance 1.8% of the time. The relationship 
is not statistically significant (~0.05) and hypothesis 5 is rejected. Further research is 
needed to determine if severity of physical symptoms determines compliance; however, 
one study by Murray et al. (2004) reported that compliance with the GFD significantly 
reduced gastrointestinal symptoms of CD (p=O.OOl) (Murray et aI., 2004). Murrayet aI. 
indicate that compliance increases as symptoms decrease to maintain a feeling of good 
health. 
Hypothesis 6: The high cost of GF foods will predict significantly decreased compliance 
with the GFD. 
The results from questions 10 and 11 on the survey show participants find GF 
foods to be more expensive than their gluten-containing counterpart 87% of the time but 
are influenced by the price 26% of the time. Hypothesis 6 predicts that the higher cost of 
GF foods will decrease compliance with the GFD. Perceived expense is positively 
correlated with current rate of compliance and predicts increased compliance 1.3% of the 
time, but is not statistically significant (p2:0.05). Influence of expense is negatively 
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correlated with current rate of compliance and predicts a decrease in compliance 22.1 % 
of the time, but it is not statistically significant (p2:0.05) and hypothesis 6 is rejected. The 
findings on perceived expense agree with Lee et al. (2007) study which concluded that 
GF foods are considerably more expensive than gluten-containing foods. 
Qualitative data 
The qualitative data collected with question 12 is consistent with the quantitative 
data collected with questions 1-11. The wide variety of challenges and strategies 
illustrate that compliance with the GFD is still an individualized issue. It also shows that 
more than one factor contributes to the decision process of CD individuals when 
considering compliance and non-compliance. This idea is supported in literature by 
studies conducted here in the United States and around the world. Olsson et al. (2008) 
concluded that adolescents face various influences associated with eating a GFD such as 
limited knowledge, limited availability of GF foods, feelings of embarrassment, and taste 
of GF foods. Zarkadas et al. (2006) concluded that CD individuals will improve 
compliance if provided with better food labels, better dietary instruction, increased 
availability of GF foods, and earlier diagnosis of the disease. Lee et al. (2007) found that 
the GFD presents a financial burden to CD individuals and may determine compliance. 
Previous research and the current study are consistent with the conclusions that 
compliance is a multi-factorial issue for CD individuals. 
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Chapter 5 
SUMMARY AND CONCLUSIONS 
The prevalence of CD is growing, affecting 1 in 133 people in the US today 
(Fasano et aI., 2003). There is no known cure for CD and the only treatment is strict 
dietary changes eliminating gluten. It is important as a practitioner to have a functional 
understanding of the condition to recognize symptoms, improve diagnostic time, and 
reduce the risk of developing additional complications (Martin, 2008). Adherence to the 
GFD will relieve physical symptoms, allow the small intestine to heal, and the process of 
malabsorption and malnutrition to be reversed. 
Summary 
Compliance with the GFD is a life-long change that presents a challenge to CD 
individuals. Factors influencing compliance are numerous and diverse. The purpose of 
this research project was to determine the influential factors of compliance and/or non­
compliance with the GFD for CD individuals. The researcher hypothesized that early 
diagnosis of CD would predict significantly improved compliance with the GFD. 
Increased knowledge of the GFD would predict significantly improved compliance with 
the GFD. Availability of GF foods would predict significantly improved compliance 
with the GFD. Social situations would increase pressures that would predict significantly 
decreased compliance with the GFD. The severity of physical symptoms of CD would 
predict significantly improved compliance with the GFD. And that the high cost of GF 
foods would predict significantly decreased compliance with the GFD. 
A survey was developed by the researcher and distributed online to a convenience 
sample of CD support group facilitators in nine Midwestern states (Illinois, Indiana, 
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Iowa, Kansas, Michigan, Minnesota, Missouri, Ohio, and Wisconsin). The survey was 
composed of 12 questions pertaining to influential factors contributing to compliance 
and/or non-compliance. The researcher found that age at diagnosis, knowledge of the 
GFD, availability of GF foods, and influence of social pressures and situations accounted 
for 24.0% of the variance in current rate of compliance with the GFD. The qualitative 
data from question 12 found that the decision to comply with the GFD is multi-factorial 
and individualized. These findings were not statistically significant and the researcher 
rejected the hypotheses; however, the data trend is in a positive direction and, with a 
larger sample, significant findings may be observed. 
Recommendations for Future Research 
Further research on factors contributing to compliance with the GFD is needed. 
There was a lack of research addressing the specific factors related to compliance. 
Studies focused on age at diagnosis and compliance with the GFD is needed to determine 
if early diagnosis of CD will significantly affect compliance. Studies that measure 
knowledge of the GFD and its effect on compliance are needed to determine if a 
significant relationship exists. Research concerning availability of GF foods and how 
availability effects compliance as well as studies on the influence of physical symptoms 
and their effect on compliance are needed. Research aimed at determining the influence 
of social situations and compliance and the influence of cost of GF foods and compliance 
with the GFD are needed to assess significant impact on compliance. 
Recommendations for Practice 
The findings of this research can be applied to the future practice of registered 
dietitians and their dietary counseling of CD patients using the GFD. The study found a 
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trend in the data suggesting knowing the patient's age at diagnosis, current knowledge of 
the GFD, availability of GF foods where they live, and the influence of social pressures 
and situations can help determine the current rate of compliance with the GFD for that 
patient. Although not the only factors contributing to compliance, these four components 
account for 24.0% of the variance in compliance rates for CD individuals living in the 
Midwest. Encouraging early diagnostic screening for CD, education on the GFD, access 
to GF foods, and strategies for overcoming social pressures and situations seem to be 
important tools for increasing compliance with the GFD for CD individuals. 
Conclusion 
CD has become more prevalent in the past decades affecting nearly three million 
Americans (Fasano et aI., 2003). It is important for practitioners to have a working 
understand of the condition in order to recognize symptoms, improve diagnostic time, 
and reduce the risk of developing additional complications (Martin, 2008). Strict 
compliance with the GFD is reported to provide protective benefits for CD patients from 
GI malignancies (Seraphin & Mobarhan, 2002)). Research conducted by Corrao et aI. in 
2002 reported by Seraphin showed this association and reported a relation between GFD 
compliance and decreased mortality rates in both symptomatic and asymptomatic CD 
patients. A standardized mortality ratio (SMR) was calculated over a six year study that 
showed an increase in deaths from small bowel lymphoma and other malignant diseases 
in patients not following the GFD (Seraphin & Mobarhan, 2002). Additional research is 
needed to determine the effects of malignant diseases associated with CD to better 
understand the relation with the GFD. 
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The current study concludes that 24.0% of the variance in current rate of 
compliance can be explained by knowing the patient's age at diagnosis, knowledge of the 
GFD, availability of GF foods where they live, and the influence of social pressures and 
situations. Understanding these and other factors influencing compliance rates is 
important for health care practitioners in order to improve educational strategies for 
effective treatment of CD using the GFD. 
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Appendix A 
Dear Celiac Disease Support Group members, 
You are invited to participate in a research study on celiac disease and the gluten-free diet 

being conducted by Jill Barnes, a graduate dietetics student at Eastern Illinois University. 

Your participation in this research project is completely voluntary and you may withdraw 

at any point with no penalty. 

You have been asked to participate in this study because you are a facilitator of a celiac 

disease support group in one of nine Midwestern states. Additional members of your 

support group are encouraged to participate and you are encouraged to forward this email 

on to other members of your support group. All members willing to participate will be 

included. No age or gender specifications have been established. Parents or legal 

guardians of children with celiac disease may help their child complete the survey if 

desired by providing access to the electronic survey via the link below. By providing 

access to the electronic survey and helping the child complete the survey, the parent or 

legal guardian is giving informed consent for the minor (17 years old or younger). 

If you choose to participate, you will have until Tuesday, June 15,2010 to complete the 

survey via kwiksurveys.com. The survey will take approximately 15 minutes or less to 

complete. To complete the survey, please follow the link at the end of this email and fill 

out the questions to the best of your ability. By clicking finish survey at the end, you will 

submit the survey. 

Completing the survey electronically presents no foreseeable risk. There is no 

anticipated discomfort or negative outcomes associated with completing the survey. 

The data collected by this research project will help health practitioners better understand 

educational techniques for dietary instruction for celiac disease individuals. By taking a 

moment to complete the survey, you will be contributing to the understanding of celiac 

disease and the challenges individuals face with the gluten-free diet. All responses to 

the survey will be confidential and anonymous. 

Please contact Jill Barnes atjlbarnes@eiu.edu or Dr. Karla Kennedy-Hagan at 

kjkennedyhagan@eiu.edu for any additional information, questions, or concerns. 

If you wish to participate, please click on the link below. By clicking the link below, you 

are giving your consent to participate in the study. 

Link: 

Jill Barnes Karla Kennedy-Hagan, PhD, RD 
Dietetics/Nutrition Graduate Student Associate Professor, DI Coordinator 
Eastern Illinois University-Charleston, IL Assistant Chair, FCS at EIU 
Phone: 217-581-6363 Fax: 217-581-6090 Email: kjkennedyhagan@eiu 
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Appendix B 
Survey 
Celiac Disease and the Gluten Free Diet 
This research project is designed to examine factors related to Celiac Disease and the 
gluten-free diet. A gluten-free diet is a diet free from wheat, barley, or rye. 
Instructions: Please answer each question to the best of your ability. 
Definition of Key words: Compliance: To conform to the guidelines; an act of 
following a prescribed treatment 
Non-Compliance: Not following a prescribed treatment 
1. 	 What is the name of the state where you live? 
2. 	 What is your gender? 
3. 	 What is your current age? 
4. 	 What was your age at the time of diagnosis of Celiac Disease? 
5. 	 Rate your current knowledge of the gluten-free diet on a scale of 1 to 10, with 1 
being not knowledgeable and 10 being always knowledgeable. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
6. 	 Rate your current compliance with the gluten-free diet on a scale of 1 to 10, with 
1 being never compliant and 10 being always compliant. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
7. 	 Rate the availability of gluten-free products where you live on a scale of 1 to 10, 
with 1 being never available and 10 being always available. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
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8. 	 Rate how influential social pressures are to your decision to comply with the 
gluten-free diet on a scale of 1 to 10, with 1 being never influential and 10 being 
always influential. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
9. 	 Rate the severity of your physical symptoms related to celiac disease on a scale of 
1 to 10, with 1 being never severe and 10 being always severe. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
10. Rate how expensive you find gluten-free foods to be in comparison to the gluten­
containing counterparts on a scale of 1 to 10, with 1 being not expensive and 10 
being very expensive. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
11. Rate how influential cost of gluten-free foods is you're your decision to comply 
with the gluten-free diet on a scale of 1 to 10, with 1 being never influential and 
10 being always influential. 
1 2 3 4 5 6 7 8 9 10 
Never Always 
12. Do you wish to share any experiences you've had will eating a gluten-free diet? 
If so, please discuss below. 
